{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["High-containment", "Monkeypox", "Orthopoxvirus", "Purification", "Variola"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "28131867", "DateCompleted": {"Year": "2017", "Month": "10", "Day": "02"}, "DateRevised": {"Year": "2022", "Month": "10", "Day": "09"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2017", "Month": "01", "Day": "26"}], "ELocationID": ["10.1016/j.jviromet.2017.01.018", "S0166-0934(16)30485-2"], "Journal": {"ISSN": "1879-0984", "JournalIssue": {"Volume": "243", "PubDate": {"Year": "2017", "Month": "May"}}, "Title": "Journal of virological methods", "ISOAbbreviation": "J Virol Methods"}, "ArticleTitle": "A rapid Orthopoxvirus purification protocol suitable for high-containment laboratories.", "Pagination": {"StartPage": "68", "EndPage": "73", "MedlinePgn": "68-73"}, "Abstract": {"AbstractText": ["Virus purification in a high-containment setting provides unique challenges due to barrier precautions and operational safety approaches that are not necessary in lower biosafety level (BSL) 2 environments. The need for high risk group pathogen diagnostic assay development, anti-viral research, pathogenesis and vaccine efficacy research necessitates work in BSL-3 and BSL-4 labs with infectious agents. When this work is performed in accordance with BSL-4 practices, modifications are often required in standard protocols. Classical virus purification techniques are difficult to execute in a BSL-3 or BSL-4 laboratory because of the work practices used in these environments. Orthopoxviruses are a family of viruses that, in some cases, requires work in a high-containment laboratory and due to size do not lend themselves to simpler purification methods. Current CDC purification techniques of orthopoxviruses uses 1,1,2-trichlorotrifluoroethane, commonly known as Genetron<sup>\u00ae</sup>. Genetron<sup>\u00ae</sup> is a chlorofluorocarbon (CFC) that has been shown to be detrimental to the ozone and has been phased out and the limited amount of product makes it no longer a feasible option for poxvirus purification purposes. Here we demonstrate a new Orthopoxvirus purification method that is suitable for high-containment laboratories and produces virus that is not only comparable to previous purification methods, but improves on purity and yield."], "CopyrightInformation": "Published by Elsevier B.V."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Electronic address: bkz2@cdc.gov."}], "LastName": "Hughes", "ForeName": "Laura", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Wilkins", "ForeName": "Kimberly", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Goldsmith", "ForeName": "Cynthia S", "Initials": "CS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Smith", "ForeName": "Scott", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Hudson", "ForeName": "Paul", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Patel", "ForeName": "Nishi", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Karem", "ForeName": "Kevin", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Damon", "ForeName": "Inger", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Li", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Olson", "ForeName": "Victoria A", "Initials": "VA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA."}], "LastName": "Satheshkumar", "ForeName": "P S", "Initials": "PS"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "J Virol Methods", "NlmUniqueID": "8005839", "ISSNLinking": "0166-0934"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Containment of Biohazards"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Laboratories"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Orthopoxvirus"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["methods"], "DescriptorName": "Virology"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Al Falluji M.M., Tantawi H.H., Al-Bana A., Al-Sheikhly S. Pox infection among captive peacocks. J. Wildl. Dis. 1979;15:597\u2013600.", "ArticleIdList": ["230366"]}, {"Citation": "Berting A., Goerner W., Spruth M., Kistner O., Kreil T.R. Effective poxvirus removal by sterile filtration during manufacture of plasma derivatives. J. Med. Virol. 2005;75:603\u2013607.", "ArticleIdList": ["15714487"]}, {"Citation": "Bogaerts W.J., Durville-van der O. Immunization of mice against encephalomyocarditis virus. I. Purification concentration, and inactivation of encephalomyocarditis virus. Infect. Immun. 1972;6:508\u2013512.", "ArticleIdList": ["PMC422566", "4344026"]}, {"Citation": "Broder C., Earl P. Recombinant vaccinia viruses. Mol. Biotechnol. 1999;13:223\u2013245.", "ArticleIdList": ["10934535"]}, {"Citation": "Canada, P.H.A.o., 2011. Monkeypox Virus."}, {"Citation": "Cyrklaff M., Risco C., Fernandez J.J., Jimenez M.V., Esteban M., Baumeister W., Carrascosa J.L. Cryo-electron tomography of vaccinia virus. Proc. Natl. Acad. Sci. U. S. A. 2005;102:2772\u20132777.", "ArticleIdList": ["PMC549483", "15699328"]}, {"Citation": "Epstein M.A. An investigation into the purifying effect of a fluorocarbon on vaccinia virus. Br. J. Exp. Pathol. 1958;39:436\u2013446.", "ArticleIdList": ["PMC2082239", "13572732"]}, {"Citation": "Heinricy U., Stierhof Y.D., Pfisterer M., Flehmig B. Properties of a hepatitis A virus candidate vaccine strain. J. Gen. Virol. 1987;68(Pt. 9):2487\u20132493.", "ArticleIdList": ["2821186"]}, {"Citation": "Huang C.-Y., Chang W. In: Vaccinia Virus and Poxvirology. Isaacs S.N., editor. Humana Press; 2012. Imaging of vaccinia virus entry into HeLa cells; pp. 123\u2013133.", "ArticleIdList": ["22688764"]}, {"Citation": "Hughes L.J., Goldstein J., Pohl J., Hooper J.W., Lee Pitts R., Townsend M.B., Bagarozzi D., Damon I.K., Karem K.L. A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27. Virology. 2014;464\u2013465:264\u2013273.", "ArticleIdList": ["PMC9629035", "25108113"]}, {"Citation": "Hutson C.L., Nakazawa Y.J., Self J., Olson V.A., Regnery R.L., Braden Z., Weiss S., Malekani J., Jackson E., Tate M., Karem K.L., Rocke T.E., Osorio J.E., Damon I.K., Carroll D.S. Laboratory investigations of African pouched rats (Cricetomys gambianus) as a potential reservoir host species for monkeypox virus. PLoS Negl. Trop. Dis. 2015;9:e0004013.", "ArticleIdList": ["PMC4627651", "26517724"]}, {"Citation": "Kleiner M., Hooper L.V., Duerkop B.A. Evaluation of methods to purify virus-like particles for metagenomic sequencing of intestinal viromes. BMC Genom. 2015;16", "ArticleIdList": ["PMC4308010", "25608871"]}, {"Citation": "Kondas A.V., Olson V.A., Li Y., Abel J., Laker M., Rose L., Wilkins K., Turner J., Kline R., Damon I.K. Variola virus-specific diagnostic assays: characterization, sensitivity, and specificity. J. Clin. Microbiol. 2015;53:1406\u20131410.", "ArticleIdList": ["PMC4365196", "25673790"]}, {"Citation": "Kontor E.J., Welch A.B. Characterisation of an epizootic haemorrhagic disease virus. Res. Vet. Sci. 1976;21:190\u2013196.", "ArticleIdList": ["968187"]}, {"Citation": "Kremer M., Volz A., Kreijtz J.C.M., Fux R., Lehmann M., Sutter G. In: Vaccinia Virus and Poxvirology. Isaacs S.N., editor. Humana Press; 2012. Easy and efficient protocols for working with recombinant vaccinia virus MVA; pp. 59\u201392.", "ArticleIdList": ["22688761"]}, {"Citation": "Moss B. Poxvirus cell entry: how many proteins does it take? Viruses. 2012;4:688\u2013707.", "ArticleIdList": ["PMC3386626", "22754644"]}, {"Citation": "Payne L.G. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J. Virol. 1979;31:147\u2013155.", "ArticleIdList": ["PMC353430", "501796"]}, {"Citation": "Payne L.G. The existence of an envelope on extracellular cowpox virus and its antigenic relationship to the vaccinia envelope. Arch. Virol. 1986;90:125\u2013133.", "ArticleIdList": ["3729722"]}, {"Citation": "Planterose D.N., Nishimura C., Salzman N.P. The purification of vaccinia virus from cell cultures. Virology. 1962;18:294\u2013301.", "ArticleIdList": ["13943950"]}, {"Citation": "Reynolds M.G., Carroll D.S., Olson V.A., Hughes C., Galley J., Likos A., Montgomery J.M., Suu-Ire R., Kwasi M.O., Jeffrey Root J., Braden Z., Abel J., Clemmons C., Regnery R., Karem K., Damon I.K. A silent enzootic of an Orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human disease. Am. J. Trop. Med. Hyg. 2010;82:746\u2013754.", "ArticleIdList": ["PMC2844556", "20348530"]}, {"Citation": "Services U.S.D.o.H.a.H., Service P.H., Prevention C.f.D.C.a., Health N.I.o. 5 ed. 2009. Biosafety in Microbiological and Biomedical Laboratories. (p. 415)"}, {"Citation": "Sun G., Xiao J., Wang H., Gong C., Pan Y., Yan S., Wang Y. Efficient purification and concentration of viruses from a large body of high turbidity seawater. MethodsX. 2014;1:197\u2013206.", "ArticleIdList": ["PMC4473021", "26150953"]}, {"Citation": "Ver B.A., Melnick J.L., Wallis C. Efficient filtration and sizing of viruses with membrane filters. J. Virol. 1968;2:21\u201325.", "ArticleIdList": ["PMC375573", "4316012"]}, {"Citation": "Welch A.B. Purification, morphology and partial characterization of a reovirus-like agent associated with neonatal calf diarrhea. Can. J. Comp. Med.: Rev. Can. Med. Comp. 1971;35:195\u2013202.", "ArticleIdList": ["PMC1319605", "4254892"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "9", "Day": "26"}, {"Year": "2017", "Month": "1", "Day": "19"}, {"Year": "2017", "Month": "1", "Day": "20"}, {"Year": "2017", "Month": "1", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "26"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28131867", "PMC9533856", "10.1016/j.jviromet.2017.01.018", "S0166-0934(16)30485-2"]}}], "PubmedBookArticle": []}